Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia Redazione 13 Maggio 2021 ...
Phase 1b trial of isatuximab, an anti‐CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma Redazione 13 Maggio 2021 ...
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant Redazione 13 Maggio 2021 ...
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score Redazione 6 Maggio 2021 ...
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors Redazione 6 Maggio 2021 ...
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects Redazione 6 Maggio 2021 ...